Literature DB >> 1328891

Kinin-induced relaxations of the rat duodenum.

T Griesbacher1.   

Abstract

Both bradykinin (BK) and des-Arg9-BK induced relaxations of the isolated longitudinal smooth muscles of the rat duodenum. No contractile effects were observed with both peptides at concentrations up to 1 mumol/l. Des-Arg9-BK was about 1000 times less potent than BK. The novel B2 antagonist HOE 140 (D-Arg-[Hyp3, Thi5, D-Phe7, Oic8]-BK) potently inhibited the BK-induced relaxations, but did not affect the relaxations induced by des-Arg9-BK. Conversely, the B1 receptor antagonist des-Arg9-[Leu8]-BK only inhibited des-Arg9-BK, but did not affect BK-induced relaxations. The relaxations induced by BK and by des-Arg9-BK were inhibited by apamin (1 mumol/l) demonstrating that apamin-sensitive K+ channels are involved. In contrast, tetraethylammonium (1 mmol/l) did not inhibit the relaxations. BK-induced relaxations were reduced by about 25% in the presence of indomethacin (10 mumol/l) although the concentration-response curve to BK was not shifted to the left. Prostaglandin E1 caused relaxations with a pD2 value of 9.2. It is concluded that both BK and des-Arg9-BK can elicit relaxations of the rat duodenum via pharmacologically distinct kinin receptor subtypes, but via similar effector mechanisms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328891     DOI: 10.1007/bf00167578

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase.

Authors:  H S Kantor; M Hampton
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

2.  Characterization of the receptors responsible for the diphasic effect of bradykinin in rat duodenum.

Authors:  C C Pereira; T B Paiva
Journal:  Braz J Med Biol Res       Date:  1989       Impact factor: 2.590

3.  Bradykinin receptors in isolated rat duodenum.

Authors:  O Altinkurt; Y Oztürk
Journal:  Peptides       Date:  1990 Jan-Feb       Impact factor: 3.750

4.  Indomethacin and ibuprofen inhibit the uptake of 45Ca2+ by washed human platelets through a thromboxane A2-independent mechanism.

Authors:  J Gill; P Dandona; J Y Jeremy
Journal:  Eur J Pharmacol       Date:  1990-10-02       Impact factor: 4.432

5.  Evidence for a pulmonary B3 bradykinin receptor.

Authors:  S G Farmer; R M Burch; S A Meeker; D E Wilkins
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

6.  Regulation of Ca2+-dependent K+-channel activity in tracheal myocytes by phosphorylation.

Authors:  H Kume; A Takai; H Tokuno; T Tomita
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

7.  Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.

Authors:  R A Coleman; P P Humphrey; I Kennedy; G P Levy; P Lumley
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

8.  Effects of bradykinin and bradykinin analogs on the opossum lower esophageal sphincter: characterization of an inhibitory bradykinin receptor.

Authors:  J K Saha; J N Sengupta; R K Goyal
Journal:  J Pharmacol Exp Ther       Date:  1991-10       Impact factor: 4.030

9.  The role of the epithelium in modulating the responses of guinea-pig trachea induced by bradykinin in vitro.

Authors:  A M Bramley; M N Samhoun; P J Piper
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

10.  Effects of angiotensin II and vasopressin on intracellular pH of glomerular mesangial cells.

Authors:  M B Ganz; G Boyarsky; W F Boron; R B Sterzel
Journal:  Am J Physiol       Date:  1988-06
View more
  1 in total

1.  Actions of bradykinin on electrical and synaptic behavior of neurones in the myenteric plexus of guinea-pig small intestine.

Authors:  Hong-Zhen Hu; Sumei Liu; Na Gao; Yun Xia; Randa Mostafa; Jun Ren; Dimiter H Zafirov; Jackie D Wood
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.